• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bone metabolism during methylprednisolone pulse therapy in rheumatoid arthritis.类风湿关节炎患者甲泼尼龙冲击治疗期间的骨代谢
Ann Rheum Dis. 1986 Sep;45(9):757-60. doi: 10.1136/ard.45.9.757.
2
Acute changes in calcium and bone metabolism during methylprednisolone pulse therapy in rheumatoid arthritis.
Br J Rheumatol. 1988 Jun;27(3):215-9. doi: 10.1093/rheumatology/27.3.215.
3
Effects of different regimes of corticosteroid treatment on calcium and bone metabolism in rheumatoid arthritis.不同皮质类固醇治疗方案对类风湿关节炎患者钙和骨代谢的影响
Clin Rheumatol. 1992 Sep;11(3):388-92. doi: 10.1007/BF02207199.
4
Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.类风湿关节炎患者大剂量糖皮质激素脉冲治疗期间骨代谢(标志物)的变化。
Ann Rheum Dis. 1996 May;55(5):288-93. doi: 10.1136/ard.55.5.288.
5
Methylprednisolone pulse therapy in conjunction with azathioprine in rheumatoid arthritis.甲泼尼龙冲击疗法联合硫唑嘌呤治疗类风湿关节炎。
Clin Rheumatol. 1986 Dec;5(4):499-504.
6
The course of hypercalciuria and related markers of bone metabolism parameters associated with corticosteroid treatment.与皮质类固醇治疗相关的高钙尿症及相关骨代谢参数的变化过程。
Ren Fail. 2012;34(3):338-42. doi: 10.3109/0886022X.2011.648596. Epub 2012 Jan 20.
7
Effect of low-dose prednisone (with calcium and calcitriol supplementation) on calcium and bone metabolism in healthy volunteers.低剂量泼尼松(联合补充钙和骨化三醇)对健康志愿者钙及骨代谢的影响
Br J Rheumatol. 1998 Jan;37(1):27-33. doi: 10.1093/rheumatology/37.1.27.
8
Biochemical markers of bone metabolism in infants and children under intravenous corticosteroid therapy.接受静脉注射皮质类固醇治疗的婴幼儿和儿童的骨代谢生化标志物。
Calcif Tissue Int. 2003 Oct;73(4):319-25. doi: 10.1007/s00223-002-2099-x. Epub 2003 Jul 24.
9
Lack of influence of the anabolic steroid nandrolondecanoate on bone metabolism.合成代谢类固醇癸酸诺龙对骨代谢无影响。
Acta Endocrinol (Copenh). 1982 Sep;101(1):140-3. doi: 10.1530/acta.0.1010140.
10
Urinary hydroxypyridinium cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone.
Br J Rheumatol. 1994 Sep;33(9):816-20. doi: 10.1093/rheumatology/33.9.816.

引用本文的文献

1
A Literature Review of the Potential Impact of Medication on Vitamin D Status.药物对维生素D状态潜在影响的文献综述
Risk Manag Healthc Policy. 2021 Aug 14;14:3357-3381. doi: 10.2147/RMHP.S316897. eCollection 2021.
2
Therapy of moderate-to-severe Graves' orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density.静脉注射甲基强的松龙脉冲治疗中重度格雷夫斯眼病与骨密度丢失无关。
Endocrine. 2019 May;64(2):308-315. doi: 10.1007/s12020-018-1823-x. Epub 2018 Dec 1.
3
Glucocorticoid-induced osteoporosis: who to treat with what agent?糖皮质激素性骨质疏松症:用什么药物治疗谁?
Nat Rev Rheumatol. 2015 Feb;11(2):98-109. doi: 10.1038/nrrheum.2014.188. Epub 2014 Nov 11.
4
Drug-vitamin D interactions: a systematic review of the literature.药物-维生素 D 相互作用:文献系统评价。
Nutr Clin Pract. 2013 Apr;28(2):194-208. doi: 10.1177/0884533612467824. Epub 2013 Jan 10.
5
Assessment of bone mineral density by dual x-ray absorptiometry in dermatological patients treated by corticosteroids.采用双能X线吸收法对接受皮质类固醇治疗的皮肤病患者进行骨密度评估。
Indian J Dermatol. 2010 Jul-Sep;55(3):238-45. doi: 10.4103/0019-5154.70669.
6
Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study.接受甲泼尼龙脉冲治疗的患者骨质流失不容忽视:一项短期前瞻性观察研究。
Ann Rheum Dis. 2004 Aug;63(8):940-4. doi: 10.1136/ard.2003.011734.
7
Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.类风湿关节炎患者大剂量糖皮质激素脉冲治疗期间骨代谢(标志物)的变化。
Ann Rheum Dis. 1996 May;55(5):288-93. doi: 10.1136/ard.55.5.288.
8
Corticosteroids and bone mass in asthma.哮喘中的皮质类固醇与骨量
Br Med J (Clin Res Ed). 1987 May 30;294(6584):1416. doi: 10.1136/bmj.294.6584.1416.
9
Bone metabolism in patients with rheumatoid arthritis.类风湿关节炎患者的骨代谢
Clin Rheumatol. 1988 Mar;7(1):16-23. doi: 10.1007/BF02284051.
10
Pulse methylprednisolone therapy in rheumatoid arthritis: unproved therapy, unjustified therapy, or effective adjunctive treatment?类风湿关节炎的脉冲式甲泼尼龙治疗:未经证实的治疗方法、不合理的治疗手段还是有效的辅助治疗?
Ann Rheum Dis. 1990 Apr;49(4):265-7. doi: 10.1136/ard.49.4.265.

本文引用的文献

1
Relevance of urinary excretion of alcian blue-glycosaminoglycans complexes and hydroxyproline to disease activity in rheumatoid arthritis.
J Rheumatol. 1982 Jul-Aug;9(4):579-83.
2
Lack of influence of the anabolic steroid nandrolondecanoate on bone metabolism.合成代谢类固醇癸酸诺龙对骨代谢无影响。
Acta Endocrinol (Copenh). 1982 Sep;101(1):140-3. doi: 10.1530/acta.0.1010140.
3
Short-term effect of prednisone on serum 1,25-dihydroxyvitamin D in normal individuals and in hyper- and hypoparathyroidism.泼尼松对正常个体以及甲状旁腺功能亢进和减退患者血清1,25 - 二羟维生素D的短期影响
Clin Endocrinol (Oxf). 1982 Jul 1;17(1):21-8. doi: 10.1111/j.1365-2265.1982.tb02630.x.
4
Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy.1α,25-二羟维生素D在结节病和吸收性高钙尿症中的发病机制作用:对泼尼松龙治疗的不同反应。
J Clin Endocrinol Metab. 1980 Aug;51(2):381-6. doi: 10.1210/jcem-51-2-381.
5
Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy.糖皮质激素治疗患者继发性甲状旁腺功能亢进症发生过程中尿钙排泄增加的重要性。
Metabolism. 1983 Feb;32(2):151-6. doi: 10.1016/0026-0495(83)90221-4.
6
A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease.
Lancet. 1982 Jul 31;2(8292):237-40. doi: 10.1016/s0140-6736(82)90323-3.
7
Osteocytic osteolysis.骨细胞性骨溶解
Calcif Tissue Res. 1969 Aug 11;4(1):1-12. doi: 10.1007/BF02279101.
8
Bone turnover in early rheumatoid arthritis. 1. Biochemical and kinetic indexes.早期类风湿关节炎中的骨转换。1. 生化及动力学指标。
Ann Rheum Dis. 1985 Sep;44(9):575-9. doi: 10.1136/ard.44.9.575.
9
Effect of glucocorticoids on function of the parathyroid glands in man.糖皮质激素对人体甲状旁腺功能的影响。
J Clin Endocrinol Metab. 1975 Jan;40(1):152-5. doi: 10.1210/jcem-40-1-152.
10
Cortisol stimulation of parathyroid hormone secretion by rat parathyroid glands in organ culture.器官培养中皮质醇对大鼠甲状旁腺分泌甲状旁腺激素的刺激作用。
Science. 1976 Sep 10;193(4257):1015-7. doi: 10.1126/science.948759.

类风湿关节炎患者甲泼尼龙冲击治疗期间的骨代谢

Bone metabolism during methylprednisolone pulse therapy in rheumatoid arthritis.

作者信息

Bijlsma J W, Duursma S A, Huber-Bruning O

出版信息

Ann Rheum Dis. 1986 Sep;45(9):757-60. doi: 10.1136/ard.45.9.757.

DOI:10.1136/ard.45.9.757
PMID:3767462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1001982/
Abstract

The deleterious effects of corticosteroids (CS) on bone are well known, but probably differ depending on duration and dosage of CS therapy. Presently huge amounts of CS are given over a short period of time in different rheumatic conditions. Not much is known about the effect of this kind of CS treatment on bone metabolism. Twenty patients with persistently active rheumatoid arthritis were treated with 1 g methylprednisolone (MP) three times on alternate days over a five day period. Twenty four hours after the first MP pulse serum calcium was increased and the values of parathyroid hormone and 1,25-dihydroxyvitamin D tended to increase. After the second MP pulse, however, these values had returned to the starting values. The urinary calcium excretion increased during MP pulse therapy and returned to the initial value immediately after the pulse therapy. The hydroxyproline excretion tended to decrease during therapy and stayed decreased immediately afterwards, indicating a decrease in bone resorption. It is concluded that bone metabolism is not seriously affected during MP pulse therapy.

摘要

皮质类固醇(CS)对骨骼的有害影响众所周知,但可能因CS治疗的持续时间和剂量而异。目前,在不同的风湿性疾病中,短期内会大量使用CS。关于这种CS治疗对骨代谢的影响,人们了解得并不多。20例持续性活动类风湿关节炎患者在5天内每隔一天接受3次1g甲泼尼龙(MP)治疗。首次MP冲击后24小时,血清钙升高,甲状旁腺激素和1,25-二羟维生素D值趋于升高。然而,第二次MP冲击后,这些值又回到了起始值。MP冲击治疗期间尿钙排泄增加,冲击治疗后立即恢复到初始值。治疗期间羟脯氨酸排泄趋于减少,随后立即保持减少,表明骨吸收减少。结论是,MP冲击治疗期间骨代谢未受到严重影响。